Literature DB >> 7928804

Bacterial resistance mechanisms as therapeutic targets.

K Coleman1, M Athalye, A Clancey, M Davison, D J Payne, C R Perry, I Chopra.   

Abstract

In the 50 years since antimicrobial agents were first introduced, bacteria have acquired a wide variety of mechanisms which have enabled them to resist the effects of these drugs. One way of overcoming this problem is to administer an antibiotic with an agent which counteracts the mechanism of resistance to that antibiotic; an example of such an approach which has already been successfully implemented is the combination of a beta-lactam antibiotic with a beta-lactamase inhibitor. This review describes antibiotic resistance mechanisms which might lend themselves to an inhibitor approach and the potential therapeutic applications of such a strategy.

Entities:  

Mesh:

Year:  1994        PMID: 7928804     DOI: 10.1093/jac/33.6.1091

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  9 in total

Review 1.  Causes and problems of nonresponse or poor response to drugs.

Authors:  P Salvà Lacombe; J A García Vicente; J Costa Pagès; P Lucio Morselli
Journal:  Drugs       Date:  1996-04       Impact factor: 9.546

Review 2.  The search for antimicrobial agents effective against bacteria resistant to multiple antibiotics.

Authors:  I Chopra; J Hodgson; B Metcalf; G Poste
Journal:  Antimicrob Agents Chemother       Date:  1997-03       Impact factor: 5.191

3.  Isolation and characterizations of clarithromycin-resistant Mycobacterium avium clinical isolates.

Authors:  Seung Heon Lee; Young Kil Park; Chang Ki Kim; Hee Jin Kim
Journal:  J Clin Lab Anal       Date:  2011       Impact factor: 2.352

4.  Phosphonamidate analogues of dipeptides with carboxypeptidase A and beta-lactamase-inhibitory activity: elucidation of the mechanism of beta-lactamase inhibition by electrospray mass spectrometry.

Authors:  D J Payne; J H Bateson; D Tolson; B Gasson; T Khushi; P Ledent; J M Frère
Journal:  Biochem J       Date:  1996-03-01       Impact factor: 3.857

5.  Intracellular expression of Peptide fusions for demonstration of protein essentiality in bacteria.

Authors:  R Edward Benson; Elizabeth B Gottlin; Dale J Christensen; Paul T Hamilton
Journal:  Antimicrob Agents Chemother       Date:  2003-09       Impact factor: 5.191

6.  Genetic basis of macrolide resistance in Mycobacterium avium isolated from patients with disseminated disease.

Authors:  K A Nash; C B Inderlied
Journal:  Antimicrob Agents Chemother       Date:  1995-12       Impact factor: 5.191

7.  CmeABC functions as a multidrug efflux system in Campylobacter jejuni.

Authors:  Jun Lin; Linda Overbye Michel; Qijing Zhang
Journal:  Antimicrob Agents Chemother       Date:  2002-07       Impact factor: 5.191

8.  A differential drug screen for compounds that select against antibiotic resistance.

Authors:  Remy Chait; Shreya Shrestha; Aakash Kaushik Shah; Jean-Baptiste Michel; Roy Kishony
Journal:  PLoS One       Date:  2010-12-08       Impact factor: 3.240

9.  The drug resistance profile of Mycobacterium abscessus group strains from Korea.

Authors:  Seung Heon Lee; Hee Kyung Yoo; Seol Hee Kim; Won-Jung Koh; Chang Ki Kim; Young Kil Park; Hee Jin Kim
Journal:  Ann Lab Med       Date:  2013-12-06       Impact factor: 3.464

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.